FORCI, BENEDETTA
FORCI, BENEDETTA
Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA)
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis
2022 Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca
Bilateral isolated facial palsy with fast recovery in infectious mononucleosis
2017 Forci, Benedetta; Novelli, Alessio; Sodero, Alessandro; Sorbi, Sandro
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study
2019 Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation
2019 Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports.
2017 Forci, B; Mariottini, A; Mechi, C; Massacesi, L; Repice, A.
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis
2019 Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments
2019 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis
2021 Mariottini A.; Filippini S.; Innocenti C.; Forci B.; Mechi C.; Barilaro A.; Fani A.; Carlucci G.; Saccardi R.; Massacesi L.; Repice A.M.
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents
2022 Mariottini Alice , Forci Benedetta , Gualdani Elisa, Romoli Monica, Repice Anna Maria, Barilaro Alessandro, Mechi Claudia, Massacesi Luca, Francesconi Paolo
Leptomeningeal enhancement analysis in diagnostic clinical setting
2015 Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Forci, B; Massacesi, L
MRI analysis of the "central vein sign" allows identification of a subset of relapsing remitting MS patients with brain pathology different from inflammatory demyelination
2019 Azzolini, F; Grammatico, M; Filippini, S; Carlucci, G; Repice, AM; Forci, B; Dallagiacoma, S; Busto, G; Fainardi, E; Massacesi, L
MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences
2019 Azzolini, F; Grammatico, M; Carlucci, G; Goanta, L; Dallagiacoma, S; Repice, AMR; Forci, B; Dipasquale, F; Marchi, L; Fainardi, E; Massacesi, L
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments
2017 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L; Repice, A
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis.
2019 Mariottini A, Innocenti C, Forci B, Magnani E, Mechi C, Barilaro A, Nistri R, Fani A, Saccardi R, Massacesi L, Repice AM.
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports
2017 Mariottini, A; Forci, B; Magnani, E; Massacesi, L; Repice, A
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis.
2021 Pasca M, Forci B, Mariottini A, Mechi C, Barilaro A, Massacesi L, Repice AM.
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience
2017 Boffa, G; Sormani, MP; Repice, AM; Curro, D; Capobianco, M; Gualandi, F; Lo Re, M; De Gobbi, M; Innocenti, C; Capello, E; Mariottini, A; Forci, B; Uccelli, A; Barilaro, A; Cottone, S; Bertolotto, A; Saccardi, R; Mancardi, GL; Massacesi, L
The Central Vein Sign identifies patients diagnosed with multiple sclerosis probably carrying different diseases and showing milder disease course
2019 Azzolini, F; Grammatico, M; Carlucci, G; Goanta, L; Dallagiacoma, S; Forci, B; Barilaro, A; Repice, AM; Busto, G; Fainardi, E; Massacesi, L